RonaldSGoMD

Oncology • Rochester, MN

Professor, Internal Medicine, Mayo Med Sch

Join to view full profile

Dr. Go is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Go's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Summary

Ronald Go, MD, is an oncologist based in Rochester, MN. He completed his medical education at the University of Santo Tomas and underwent residency in Internal Medicine at Baylor College of Medicine, followed by a fellowship in Hematology and Medical Oncology at the Mayo Clinic College of Medicine and Science. Currently, he is a professor at the Mayo Clinic College of Medicine, with a previous tenure as a staff physician at Gundersen Lutheran Medical Center. He specializes in classical hematology including conditions such as autoimmune hemolytic anemia and immune thrombocytopenia as well as histiocytic disorders such as Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1996 - 2000
Baylor College of MedicineResidency, Internal Medicine, 1993 - 1996
University of Santo TomasClass of 1991

Certifications & Licensure

AZ State Medical License 1998 - Present
MN State Medical License 2010 - 2025
IA State Medical License 2010 - 2014
WI State Medical License 2000 - 2013
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma Start of enrollment: 2004 Jan 13
Completed
Phase 2
Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2003 Jun 01
Completed
Phase 2
Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) Start of enrollment: 2008 Jan 01
Terminated
Initial Treatment of Patients With Immune Thrombocytopenic Purpura Start of enrollment: 2010 Jan 01
Terminated
Phase 3
Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study Start of enrollment: 2010 Jun 01
Completed
Join now to see all

Publications & Presentations

PubMed

Hypofractionated Radiation Therapy for Subcutaneous Rosai-Dorfman Disease: A Case Report.
Rachael M Guenzel, William G Breen, Ronald S Go, Andrew L Feldman, Scott C Lester
Advances in Radiation Oncology. 2025-03-01
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants.
Aldo A Acosta-Medina, Jithma P Abeykoon, Saurabh Zanwar, Gordon J Ruan, Karen L Rech
Leukemia. 2025-02-11
Methotrexate and cytarabine in adult LCH: High risk, high reward and maintenance free?
Jithma P Abeykoon, Ronald S Go, Levi-Dan Azoulay, Julien Haroche
British Journal of Haematology. 2025-02-01

Journal Articles

Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma
S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse
Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia
Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy: Failure of the Serum Free Light Chain Ratio
Morie A Gertz, David Dingli, Miriam Hobbs, John A Lust, Ronald S Go, Amie Fonder, Yi Lin, Shaji K Kumar, Prashant Kapoor, Taxiarchis V Kourelis, S Vincent Rajkumar, Ro..., Nature
Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...
John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
Join now to see all

Abstracts/Posters

Molecular Alterations in Adult Histiocytic Neoplasms
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Prospective Pilot Study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed or Relapsed/Refractory POEMS Syndrome
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Mortality of Patients with Multiple Myeloma after the Introduction of Novel Therapies in the United States
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Impact of sFLC Ratio on Outcome in Patients with MM: Validating the Utility of sFLC in Response Definition
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Sex Differences in Faculty Rank and Leadership Positions Amongst Hematologists and Oncologists in United States: A Cross-Sectional Study
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Lectures

Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Association between Treatment Facility Volume and Mortality of Patients with Hodgkin Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Long-Term Survivorship with Active Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Development of Thrombocytopenia and Survival Outcomes in Newly Diagnosed Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Prognostic Value of Clone Size in Paroxysmal Nocturnal Hemoglobinuria (PNH) for Thrombotic Events in Untreated Patients in the International PNH Registry
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Clinical and Laboratory Diagnosis of Red Blood Cell Disorders: A Case-Based Algorithmic Approach
60th American Society of Hematology Annual Meeting - 11/30/2018
Join now to see all

Press Mentions

Lab Medicine Edition | CBC: White Blood Cell Count (WBC) (Leukocytosis, Leukopenia)May 2nd, 2024
Expert Care, Teamwork Lead to Tailored Treatment for Alexa’s Rare CancerJanuary 10th, 2020
Clinical Challenges: Secondary ITPDecember 5th, 2018
Join now to see all